Somatotroph

Somatotrophs are the growth hormone-producing cells of the anterior pituitary and its most numerous cell type, making up something on the order of a third to a half of the gland. They are acidophils packed with dense secretory granules, which is why they release stored hormone within minutes of stimulation rather than having to synthesise it first. Their identity is set during development by the transcription factor POU1F1, the same lineage factor that specifies lactotrophs and thyrotrophs, which explains why mutations in it cause combined deficiency of growth hormone, prolactin and TSH.

The cell is where the axis is integrated. GHRH acting through Gs raises cyclic AMP and stimulates both secretion and growth hormone gene transcription; somatostatin acting through Gi opposes it; ghrelin and synthetic secretagogues act through GHS-R1a and the Gq pathway. Mammosomatotrophs, cells that make both growth hormone and prolactin, sit at the boundary of the lineage and are the reason some pituitary adenomas cosecrete the two.

Understanding somatotrophs as a finite population with finite granule stores explains features of the axis that are otherwise puzzling: why a stimulated response has a ceiling, why closely spaced stimuli give diminishing pulses, and why pituitary damage from surgery or radiotherapy produces a deficiency no secretagogue can overcome. Testing that provokes the cell is therefore testing pituitary reserve, not hypothalamic function.

The clinically important abnormality is the somatotroph adenoma, the cause of nearly all acromegaly. In a substantial minority these tumours carry an activating mutation in the GNAS gene that locks the Gs pathway on, so the cell behaves as if GHRH were permanently present. That is what autonomy means in this setting, and it is why such a tumour ignores the glucose suppression test that a normal cell obeys.